39 reports

The company has received approval for tbo-filgrastim (XM## filgrastim).

  • Hormone
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • Official Title

Amenorrhea Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Amenorrhea Global Clinical Trials Review, H1, 2017" provides an overview of Amenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Amenorrhea. Report includes an...

  • Genitourinary System Disease
  • Hormone
  • World
  • Product Initiative
  • Repros Therapeutics Inc.
  • Clinical Trial profile. 59 Trial Title

Ovarian Disease Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Ovarian Disease Global Clinical Trials Review, H1, 2018" provides an overview of Ovarian Disease clinical trials scenario.This report provides top line data relating to the clinical trials on Ovarian...

  • Clinical Trial
  • Endocrine Disease
  • Hormone
  • Pharmaceutical
  • World
  • Target

Menstrual Disorders Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Menstrual Disorders Global Clinical Trials Review, H2, 2017" provides an overview of Menstrual Disorders clinical trials scenario. This report provides top line data relating to the clinical trials...

  • Clinical Trial
  • Hormone
  • Therapy
  • World
  • Bayer AG

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## ## Bayer AG ## ## ## ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## ## AstraZeneca Plc ## ## ## ##

  • Cancer
  • Clinical Trial
  • Hormone
  • Oncology
  • Novartis AG

Location: Hall ##.

  • Breast Cancer
  • Chemotherapy
  • Clinical Trial
  • Hormone
  • Monoclonal Antibody
  • Clinical Trial profile. 1420 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormone
  • Pharmaceutical
  • Therapy
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormone
  • Monoclonal Antibody
  • Oncology
  • Prostate Cancer
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

Merck KG ## ## ## ## ## Pfizer Inc Park Active Molecules Pantarhei Bioscience BV Health Ever Bio-Tech Co Ltd ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Ferring Holding SA ## ## ## ## ## AlphaMab Co Ltd ## ## ## ## ## Abbott Laboratories A.

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • Pharmaceutical
  • Urology
  • Clinical Trial profile. 71 Trial Title

## ## ## ## ## Novartis AG ## ## ## ## ## ## Merck & Co., Inc. ## ## ## ## ## ## Pfizer Inc. ## ## ## ## ## ## Abbott Laboratories ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## Allergan

  • Clinical Trial
  • Hormone
  • Pharmaceutical
  • World
  • Product Initiative
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

The prominent features of this report are - ##.

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • Therapy
  • Urology
  • 5. All the trials included are unique trials.

## ## ## ## ## ## China ## ## ## ## ## ## ## ## India ## ## ## ## ## ## ## ## Mexico ## ## ## ## ## ## ## ## Russia ## ## ## ## ## ## ## ## Turkey Source: GlobalData' s Pharma Intelligence Center Clinical Trials Datab

  • Clinical Trial
  • Hormone
  • World
  • Product Initiative
  • Pfizer Inc.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • World
  • Bayer AG

The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropoietin, filgrastim, follicle stimulating hormone (FSH), rituximab, ampicillin, albendazole, benezepril, and caprofen, among others.

  • Hormone
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Amgen Inc.

Detailed results of RILOMET-## will be submitted for presentation and publication.

  • Hormone
  • Therapy
  • World
  • Product Initiative
  • AnGes MG, Inc.
  • 5. All the trials included are unique trials.

WCE Oral Presentation Details: Date and Time: May ##, 2017 from ##:## to ##:## p. m.

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • Therapy
  • World
  • 4. Drug/Molecule refers to Primary Intervention only.

The prominent features of this report are - ##.

  • Hormone
  • Maternal Health
  • Therapy
  • World
  • Social Conditions

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Hormone
  • World
  • Pfizer Inc.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Hormone
  • Hospital
  • Neurology

The only one big producer is Pfizer Pharmaceutical Co., Ltd.

  • Hormone
  • Pharmaceutical
  • Prostate Cancer
  • China
  • Demand

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Hormone
  • Hospital
  • Neurology
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormone
  • Hospital
  • Renal Disease
  • Therapy

The molecules developed by Companies in Phase II, Phase I, IND/ CTA Filed, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Hormone
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Hormone
  • Hospital
  • Neurological Disorder
  • Neurology

AMONG THE MAJOR ## MANUFACTURERS, ## IN GUANGDONG PROVINCE, ## IN SHANGHAI, ## IN ZHEJIANG PROVINCE, ## IN ANHUI PROVINCE, ## IN BEIJING AND ## IN HUBEI PROVINCE.

  • Hormone
  • China
  • East Asia
  • Demand
  • Zhejiang Expressway Co., Ltd.

The auto exports exceeded over ## million each year.

  • Hormone
  • China
  • AstraZeneca Pharmaceutical Co., Ltd
  • Bristol-Myers Squibb Company
  • Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.

In the same year, Sandoz extended its leadership in biosimilars after receiving the US approval for Zarxio (filgrastim).

  • Hormone
  • United States
  • World
  • Market Size
  • Strongbridge Biopharma plc

Hoffmann-La Roche Ltd. ## ## ## ## Eli Lilly and Company ## ## ## ## AstraZeneca Plc ## ## ## ## Advanced Accelerator Applications S. A. ## ## ## ## AbbVie Inc. ## ## ## ## Celgene Corporation ## ## ## ## Source: GlobalData' s Pharma eTrack Clinical

  • Cancer
  • Chemotherapy
  • Hormone
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Hoffmann-La Roche Ltd Novartis AG ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## ## AbbVie Inc ## ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## ## Merc

  • Clinical Trial
  • Drug Discovery And Development
  • Hormone
  • Therapy
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • Hormones
  • Pharmaceutical